CAROLINE BRASHER: Open Payments
NPI 1417647868 · LUFKIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 45 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,034 · 2025 $857
Food & beverage: $857
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $238 |
| AstraZeneca Pharmaceuticals LP | 8 | $166 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $90 |
| GlaxoSmithKline, LLC. | 4 | $79 |
| Lilly USA, LLC | 4 | $70 |
| PFIZER INC. | 3 | $63 |
| Dexcom, Inc. | 2 | $50 |
| Exact Sciences Corporation | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Amgen Inc. | 1 | $21 |
Products named: Ozempic, JARDIANCE, TRELEGY ELLIPTA, Rybelsus, ELIQUIS, FARXIGA, BREZTRI, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
